| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/08/2006 | WO2006059879A1 Radioactive chitosan complex having an improved stabilized gelatin in administering them to the body and their preparation method |
| 06/08/2006 | WO2006059861A1 Pharmaceutical composition for enhancing sexual activity comprising flavonoids from rhus verniciflua |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | WO2006059785A1 Development of bioactive agent using dendritic cell differentiation-inducing factor |
| 06/08/2006 | WO2006059778A1 Substituted pyridone derivative |
| 06/08/2006 | WO2006059777A1 Remedy for alzheimer’s disease |
| 06/08/2006 | WO2006059768A1 9,10-secopregnane derivative and medicine |
| 06/08/2006 | WO2006059764A2 Enhancer of the effect of adrenocorticoid, comprising gum arabic |
| 06/08/2006 | WO2006059753A1 Novel oral pharmaceutical suspension of cefdinir crystal |
| 06/08/2006 | WO2006059744A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 06/08/2006 | WO2006059730A1 Composition for body fat reduction |
| 06/08/2006 | WO2006059716A1 Solid preparation |
| 06/08/2006 | WO2006059714A1 Composition for prevention and/or treatment of bone diseases, physiologically functional or health foods containing the composition, and medicinal preparations containing the composition as the active ingredient |
| 06/08/2006 | WO2006059713A1 Preventive and/or therapeutic agent for drug dependence |
| 06/08/2006 | WO2006059670A1 Chitosan complex |
| 06/08/2006 | WO2006059637A1 Agent for diagnosing, preventing and treating adhesion with the use of ccr8 inhibitor |
| 06/08/2006 | WO2006059507A1 11β-HSD1 ANTISENSE COMPOUND |
| 06/08/2006 | WO2006059423A1 Medicine for treatment of disease caused by hyperstimulatory cytotoxicity and therapeutic method |
| 06/08/2006 | WO2006059400A1 Antibiotics fki-2140, method of producing the same and strain producing the same |
| 06/08/2006 | WO2006059357A2 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/ or reversing ocular diseases related with ocular neovascularization |
| 06/08/2006 | WO2006059344A1 Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection |
| 06/08/2006 | WO2006059234A2 Bicyclic amides as kinase inhibitors |
| 06/08/2006 | WO2006059224A1 Pharmaceutical compositions of amorphous atorvastatin and process for preparing same |
| 06/08/2006 | WO2006059221A2 Topical hydro-alcoholic formulations of oxazolidinone antibacterial agents |
| 06/08/2006 | WO2006059217A1 Stable solid dosage forms of amlodipine besylate and processes for their preparation |
| 06/08/2006 | WO2006059210A2 Fused bicyclic pyrrols as hmg-coa reductase inhibitors |
| 06/08/2006 | WO2006059196A1 Compositions for the acute and/or long term treatment of periodontal diseases |
| 06/08/2006 | WO2006059169A2 Antiviral and immunostimulating marine fish oil composition |
| 06/08/2006 | WO2006059165A1 Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase |
| 06/08/2006 | WO2006059164A2 Pyrrolopyridine-2-carboxylic acid amides |
| 06/08/2006 | WO2006059163A1 Treatment of diabetes with glycogen phosphorylase inhibitors |
| 06/08/2006 | WO2006059152A2 Pharmaceutical formulations |
| 06/08/2006 | WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | WO2006059142A1 Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof |
| 06/08/2006 | WO2006059083A1 Neutralising agents for boronic acid drugs |
| 06/08/2006 | WO2006059082A1 Oxidised lipids as reversal agents for boronic acid drugs |
| 06/08/2006 | WO2006059078A1 Cosmetic patch for skin treatment |
| 06/08/2006 | WO2006059063A2 Perfluorocarbon liquids as carcinogen |
| 06/08/2006 | WO2006058940A1 Use of amygdalin analogues for the treatment of psoriasis |
| 06/08/2006 | WO2006058923A1 Heteroaromatic glucokinase activators |
| 06/08/2006 | WO2006058920A1 Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by anti-retroviral treatment of hiv-infected patients |
| 06/08/2006 | WO2006058905A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY |
| 06/08/2006 | WO2006058893A2 Use of diacetyl trimer as an aromatic and flavouring substance |
| 06/08/2006 | WO2006058879A1 Novel diazabicyclic aryl derivatives as cholinergy ligands |
| 06/08/2006 | WO2006058868A2 Substituted pteridines for treating inflammatory diseases |
| 06/08/2006 | WO2006058867A2 Substituted pteridines for the treatment of inflammatory diseases |
| 06/08/2006 | WO2006058781A2 Finasteride, dutasteride and related compounds for preventing/treating neurologically-associated disorders |
| 06/08/2006 | WO2006058753A1 Triazole compounds suitable for treating disorders that respond to modulaiont of the dopamine d3 receptor |
| 06/08/2006 | WO2006058752A1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases |
| 06/08/2006 | WO2006058748A1 Use of megestrol acetate for improving heart function and the treatment of heart insufficiency |
| 06/08/2006 | WO2006058724A1 New pyridothienopyrimidine derivatives |
| 06/08/2006 | WO2006058723A1 New pyridothienopyrimidine derivatives |
| 06/08/2006 | WO2006058720A2 Novel compounds for the treatment of neurological disorders |
| 06/08/2006 | WO2006058695A1 Increasing the protein concentration of animal organisms |
| 06/08/2006 | WO2006058649A1 3-substituted pyridine derivatives as h3 antagonists |
| 06/08/2006 | WO2006058630A1 Cyclic iminocarbamates and use thereof |
| 06/08/2006 | WO2006058628A2 Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes |
| 06/08/2006 | WO2006058597A1 Tetrahydropyrane derivatives for use as antidiabetics |
| 06/08/2006 | WO2006058592A1 Novel specific caspase-10 inhibitors |
| 06/08/2006 | WO2006058546A1 Novel lactame derivatives as renin inhibitors |
| 06/08/2006 | WO2006058536A1 Method of providing fast relief to a user of a nicotine chewing gum |
| 06/08/2006 | WO2006058486A1 Use of arginase in combination with 5fu and other compounds for treatment of human malignancies |
| 06/08/2006 | WO2006058483A1 USE OF 3, 4’,5-TRIHYDROXY-STILBENE-3- β-D-GLUCOSIDE IN PREPARATION OF MEDICINES FOR TREATING AND/OR PREVENTING ISCHEMIC HEART DISEASE |
| 06/08/2006 | WO2006058457A1 α-SUBSTITUTED 2-METHYL-5-NITROIMIDAZOL-1-ETHANOL DERIVATIVES |
| 06/08/2006 | WO2006058425A1 Sparc promoter mutations associated with drug resistance, and methods, oligonucleotides, cells and arrays associated therewith |
| 06/08/2006 | WO2006058411A1 Pyridoxal-5´-phosphate and related compounds in combination with therapeutic cadiovascular compounds for treating angina. |
| 06/08/2006 | WO2006044958A8 Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 06/08/2006 | WO2006044602A9 Diphenyl substituted alkanes as flap inhiibitors |
| 06/08/2006 | WO2006044504A8 Cgrp receptor antagonists |
| 06/08/2006 | WO2006044330A3 Anticancer compounds and methods |
| 06/08/2006 | WO2006044174A3 Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor |
| 06/08/2006 | WO2006042200A3 Method for synthesis of beta-glucans |
| 06/08/2006 | WO2006042021A3 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
| 06/08/2006 | WO2006040451A3 Novel 9h-pyrido[2,3-b]indole derivatives serving as cdk and gsk3 inhibitors, method for the preparation thereof, and the pharmaceutical compositions containing such compounds |
| 06/08/2006 | WO2006037869A3 Fluorophosphonocinnamic compounds, synthesis and uses for treating disorders caused by oxidative stress |
| 06/08/2006 | WO2006035280A8 3,4-dihydroisoquinoline compounds as muscrinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases |
| 06/08/2006 | WO2006034632A8 New prazole compound and the use thereof |
| 06/08/2006 | WO2006034512A3 Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes |
| 06/08/2006 | WO2006034465A8 Memantine for the treatment of childhood behavioral disorders |
| 06/08/2006 | WO2006033948A3 Sustained local anesthetic composition containing preferably a sugar ester such as saib |
| 06/08/2006 | WO2006032232A3 Novel lysolipin biosynthesis gene cluster |
| 06/08/2006 | WO2006031566A3 Halogenated benzamide derivatives |
| 06/08/2006 | WO2006029303A3 Diphenyl ether derivatives and their use for imaging serotonin transporters |
| 06/08/2006 | WO2006027691A3 Methods of treating mood disorders using benzisoxazole containing diazabicyclic compounds |
| 06/08/2006 | WO2006027474A3 Novel imidazopyridine derivatives having an affinity with respect to melatonin receptors, method for the preparation thereof and pharmaceutical compositions containing said derivatives |
| 06/08/2006 | WO2006026533A3 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors |
| 06/08/2006 | WO2006026524A3 Werner's syndrome helicase as a target for anti-hiv/aids therapy |
| 06/08/2006 | WO2006023400A3 Chemical compounds |
| 06/08/2006 | WO2006023395A3 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-(substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors |
| 06/08/2006 | WO2006021656A3 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 06/08/2006 | WO2006019940A3 Pyrrolo(oxo)quinolines as 5ht ligands |
| 06/08/2006 | WO2006018182A8 Combinations for the treatment of diseases involving cell proliferation |
| 06/08/2006 | WO2006017347B1 Opthalmic compositions and methods for treating ophthalmic conditions |
| 06/08/2006 | WO2006016828A3 Use of alpha ketoglutarate for treating alzheimer, parkinson |
| 06/08/2006 | WO2006016115A3 Method and means for enhanced pulmonary drug delivery |
| 06/08/2006 | WO2006013420B1 Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (bph) |
| 06/08/2006 | WO2006012476A3 Method for treating nervous system disorders and conditions |
| 06/08/2006 | WO2006011024A9 New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/08/2006 | WO2006010749A3 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 06/08/2006 | WO2006010620A3 Olanzapine salts and their conversion to olanzapine free base |